ArticleJournal of racial and ethnic health disparities2026
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionProstate cancer (PCa) is the second most diagnosed cancer in men, with Black and African American men (BAAM) experiencing higher incidence, more aggressive disease, and greater risk of biochemical recurrence (BCR) following radical prostatectomy (RP). This study investigated the use of
methodsThis retrospective study included 49 men with BCR post-RP: 17 BAAM and 32 White American men (WAM) who underwent
resultsThe overall detection rate was 57% (28/49), with 47% (8/17) in BAAM and 63% (20/32) in WAM (p = 0.39). BAAM had significantly higher baseline PSA levels (median: 13.80 versus 7.22 ng/mL; p < 0.001) and PSA density (0.59 versus 0.16 ng/mL²;p < 0.001). At recurrence, PSA levels and lesion distribution were statistically similar. While WAM exhibited slightly higher SUVmax and SUVmean, BAAM demonstrated higher PSMA-TV, TL-PSMA, and whole-body volumetrics (wbPSMA-TV and wbTL-PSMA); although the differences were not statistically significant, they highlight areas for future exploration.
conclusionDespite BAAM presenting with more aggressive features at primary diagnosis, BAAM and WAM exhibited comparable PSMA-PET-derived tumor burden at recurrence. These findings will inform future studies with large, racially diverse populations.
Indexed as
Identifiers
42101556What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.